Name | methyl (1S,4aS,5R,7aS)-5-hydroxy-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate |
---|---|
Synonyms |
Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-D-glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)-, methyl ester, (1S,4aS,5R,7aS)-
6β-hydroxygeniposide Scandoside methyl ester desacetylasperulosidic acid methyl ester methyl deacetylasperulosidate Methyl (1S,4aS,5R,7aS)-1-(β-D-glucopyranosyloxy)-5-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate 6beta-hydroxygeniposide deacetyl asperulosidic acid 10-O-deacetylasperulosidic acid methyl ester I07-0201 deacetylasperulosidic acid methyl ester Feretoside |
Description | Feretoside, a phenolic compound extracted from the barks of E. ulmoides, is a HSP inducer which act as cytoprotective agent. |
---|---|
Related Catalog | |
Target |
HSP[1] |
In Vitro | The barks of Eucommia ulmoides (Eucommiae Cortex, Eucommiaceae) have been used as a traditional medicine in Korea, Japan, and China to treat hypertension, reinforce the muscles and bones, and recover the damaged liver and kidney functions. Feretoside increases expression of HSF1 by a factor of 1.214, 1.144, 1.153, 1.114, 1.159, 1.041, and 1.167 at 3 mm, respectively[1]. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 696.3±55.0 °C at 760 mmHg |
Molecular Formula | C17H24O11 |
Molecular Weight | 404.366 |
Flash Point | 250.9±25.0 °C |
Exact Mass | 404.131866 |
PSA | 175.37000 |
LogP | -2.72 |
Vapour Pressure | 0.0±5.0 mmHg at 25°C |
Index of Refraction | 1.641 |
Hazard Codes | Xi |
---|